Literature DB >> 15086071

Peripheral arterial disease. A systemic disease extending beyond the affected extremity.

Daniel G Federman1, Dawn M Bravata, Robert S Kirsner.   

Abstract

Peripheral arterial disease (PAD) is a manifestation of the atherosclerotic process and is associated with an increased risk of cerebrovascular disease, cardiovascular disease, and death. Clinicians should consider screening both asymptomatic and symptomatic patients with the ankle-brachial index, a test with a high sensitivity and specificity. For those patients with PAD, atherosclerotic risk factors (such as smoking, dyslipidemia, hypertension, and diabetes mellitus) should be aggressively treated. In addition to exercise therapy, there is evidence available to support the use of aspirin, clopidogrel, lipid-lowering agents, pentoxifylline, and cilostazol.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15086071

Source DB:  PubMed          Journal:  Geriatrics        ISSN: 0016-867X


  5 in total

1.  Predictors of change in omega-3 index with fish oil supplementation in peripheral artery disease.

Authors:  Laura M Drudi; Melinda S Schaller; Jade Hiramoto; Warren Gasper; William S Harris; Nancy K Hills; S Marlene Grenon
Journal:  J Surg Res       Date:  2016-11-11       Impact factor: 2.192

2.  Far infra-red therapy promotes ischemia-induced angiogenesis in diabetic mice and restores high glucose-suppressed endothelial progenitor cell functions.

Authors:  Po-Hsun Huang; Jaw-Wen Chen; Chih-Pei Lin; Ying-Hwa Chen; Chao-Hung Wang; Hsin-Bang Leu; Shing-Jong Lin
Journal:  Cardiovasc Diabetol       Date:  2012-08-15       Impact factor: 9.951

3.  Coenzyme Q10 Attenuates High Glucose-Induced Endothelial Progenitor Cell Dysfunction through AMP-Activated Protein Kinase Pathways.

Authors:  Hsiao-Ya Tsai; Chih-Pei Lin; Po-Hsun Huang; Szu-Yuan Li; Jia-Shiong Chen; Feng-Yen Lin; Jaw-Wen Chen; Shing-Jong Lin
Journal:  J Diabetes Res       Date:  2015-11-22       Impact factor: 4.011

4.  Decreased phosphorylation of PDGFR-β impairs the angiogenic potential of expanded endothelial progenitor cells via the inhibition of PI3K/Akt signaling.

Authors:  Haiyuan Lu; Hua Mei; Fan Wang; Qian Zhao; Siqi Wang; Lvjun Liu; Lamei Cheng
Journal:  Int J Mol Med       Date:  2017-05-05       Impact factor: 4.101

5.  Secretoneurin gene therapy improves blood flow in an ischemia model in type 1 diabetic mice by enhancing therapeutic neovascularization.

Authors:  Wilfried Schgoer; Markus Theurl; Karin Albrecht-Schgoer; Verena Jonach; Bernhard Koller; Daniela Lener; Wolfgang M Franz; Rudolf Kirchmair
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.